Baker Tilly Wealth Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,042
Closed -$149K 546
2022
Q3
$149K Sell
12,042
-3,392
-22% -$59.3K 0.02% 487
2022
Q2
$303K Sell
15,434
-74
-0.5% -$1.75K 0.04% 410
2022
Q1
$405K Buy
15,508
+793
+5% +$21.1K 0.04% 388
2021
Q4
$418K Buy
14,715
+872
+6% +$27.1K 0.04% 386
2021
Q3
$441K Buy
13,843
+15
+0.1% +$503 0.06% 349
2021
Q2
$480K Buy
13,828
+106
+0.8% +$3.5K 0.08% 284
2021
Q1
$404K Buy
+13,722
New +$422K 0.08% 286

Other funds holding ELAN

Baker Tilly Wealth Management's ELAN Position: Q4 2022 in Review

Baker Tilly Wealth Management sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 12,042 shares — an estimated $149K sold.

Baker Tilly Wealth Management first reported a position in ELAN in Q1 2021 and held it in 7 quarters. The position peaked at $480K in Q2 2021. 404 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Baker Tilly Wealth Management reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 12,042 Elanco Animal Health shares in Q4 2022, an estimated $149K.
  • Baker Tilly Wealth Management first reported a position in Elanco Animal Health in Q1 2021 and held it in 7 quarters.
  • Baker Tilly Wealth Management's Elanco Animal Health position peaked at $480K in Q2 2021.
  • 404 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Baker Tilly Wealth Management's 13F filing for Q4 2022, filed 26 Jan 2023.